You are here : Home > Platforms & Infrastructures > The Institute within National ... > France Life Imaging

France Life Imaging

​France Life Imaging (FLI) is a National Infrastructure in Biology and Health that coordinates and standardizes French technological research in preclinical and clinical imaging. It offers equipment covering all types of imaging at the highest level of development to the scientific community.

Published on 28 November 2017

​Its missions

  • Coordinate at the national level in vivo research activities in imaging and unite skills to overcome current technological barriers, directing efforts at: contrast agents and diagnostic biomarkers, processing of images, instrumentation and technological innovation, interventional imaging and therapy technologies guided by imaging
  • Provide  scientists, academics, and industry the access to a complete range of imaging technologies (150 imaging systems) and integrated, standardized high-quality systems 
  • Offer trainings associated with imaging platforms


Organisation

Coordinated byJacques Bittoun, directeur of our Institute, assisted by an operational manager (Régine Trebossen), FLI is divided into 6 regional nodes: Bordeaux, Grenoble, Lyon, Marseille, Paris Center and Paris Sud. The CEA contributes to the node Paris Sud through the participation of the Frédéric Joliot Institute for Life Sciences and the institute of biology François Jacob (MIRCen). An additional cross-sectional node is devoted to data management and analysis. FLI organizes its research according to 4 axes: imaging agents, instrumentation, image processing, interventional imaging.

The Frédéric Joliot Institute for Life Sciences and FLI

 Research Teams and platforms of the SHFJ and NeuroSpin are involved in FLI. They provide expertise in the following areas:

  • Technological innovation in instrumentation, particularly for high-field MRI
  • Multimodal imaging (PET, MRI) and its applications
  • Management and processing of information (images, biological and genetic information)
  • Imaging agents (marking of the macromolecules)
  • Interventional imaging (ultrasonic treatments under MRI)
 
Multimodal brain imaging
These images of the brain are obtained by superimposing MRI images that provide information on the anatomy of the brain and images acquired by positron emission tomography (PET) that provide functional data. Here, PET is used to study changes in the functioning of dopaminergic circuits. Changes are observed in many diseases: addictions, schizophrenia, Parkinson's disease. Credit: SHFJ / CEA

 


Top page